Welcome to the 9th CAR-TCR Summit!
Are you and your team focusing on manufacturing efficiency, solid tumor durability, accessibility, safety, cost-efficiency, product release times, autoimmune indications, armoring, potency assays, resistance or investment for your cell therapy pipelines this year?
The 9th CAR-TCR Summit agenda has been created in collaboration with the cell therapy industry, for the cell therapy industry to address common challenges like these and many more. If you want to discuss these topics with like-minded industry experts and leading academics, then this is the only meeting you need to attend in 2024.
You will gain in-depth insights that are specific to your functional role, whether your focus is on Discovery, Translation, Clinical Development, Early-Stage Manufacturing, Late-Stage Manufacturing, Analytical Development or Supply Chain & Clinical Operations.
Plus, enjoy improved networking opportunities, new bonus days, reduced rates, drinks receptions, scientific poster sessions and more.
With recent expanded approvals for BMS’s Breyanzi and Johnson & Johnson’s Carvykti and further approvals set for this year, join your industry at this pivotal time to celebrate the successes and overcome challenges together to deliver more curative treatments to the ever-growing population of patients in need.